B Szende, G Barna, Kálmán Magyar
Index: J. Neural Transm. Gen. Sect. 117(6) , 695-8, (2010)
Full Text: HTML
Postulated cytoprotective action of (-)-deprenyl (D), (-)-desmethyl-deprenyl (DD) and (-)-deprenyl-N-oxide (DNO) on L-buthionine-(S,R)-sulfoximine (BSO) toxicity was investigated using in vitro cultures of serum-deprived A-2058 melanoma cells. BSO (10 microM/l) decreased viable cell number and mitotic rate, while increased the apoptotic index. D and both of its metabolites, given together with BSO in the concentration of 50 microM/l, mitigated cell loss and decreased the apoptotic ratio. DD was the most effective compound in decreasing apoptotic activity, while DNO stabilized the cell number on control level and increasing the ratio of mitotic cells above the only serum-deprived control. Surveillance on mitochondrial membrane stability and antioxidant properties may play an important role in these processes.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Desmethylselegiline
CAS:18913-84-3 |
C12H15N |
Simultaneous determination of selegiline and desmethylselegi...
2006-12-05 [J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 844(2) , 283-91, (2006)] |
Modulation of neuroendocrine--immune signaling by L-deprenyl...
2002-04-30 [Mech. Ageing Dev. 123(8) , 1065-79, (2002)] |
Pharmacokinetic studies of (-)-deprenyl and some of its meta...
2007-01-01 [J. Neural Transm. Suppl. (72) , 165-73, (2007)] |
P450 phenotyping of the metabolism of selegiline to desmethy...
2007-04-01 [Drug Metab. Pharmacokinet. 22(2) , 78-87, (2007)] |
Multiple-dose pharmacokinetics of selegiline and desmethylse...
2000-01-01 [Clin. Neuropharmacol. 23(1) , 22-7, (2000)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved